Alzheimer Dementia (AD) Completed Phase 4 Trials for Memantine (DB01043)

Also known as: Alzheimer's Dementia / Alzheimer Dementia

IndicationStatusPhase
DBCOND0078271 (Alzheimer Dementia (AD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02553928Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With AlzheimerTreatment